cardiovascular (heart) disease

Bayer and Vanderbilt University Medical Center to advance treatments for cardiovascular and kidney diseases 

The collaboration will leverage VUMC’s resource platform, including its comprehensive datasets hosted in Vanderbilt’s BioVU collection of DNA and plasma to enable data-driven insights and to accelerate discovery and development.

Scenes from the Greater Nashville Heart Walk

The event, which featured more than 50 teams from VUMC, raises awareness and funds for research, advocacy and CPR training to combat heart disease and stroke.

From stadium to stents, quick response saves soccer fan

When her evening pivoted from cheering for Nashville Soccer Club to suffering a heart attack, well-coordinated teams kept Leigh Anne Clark’s heart and life safe.

VUMC team finds potential target to slow atherosclerosis

The research findings suggest that regulating the immune response to high cholesterol through the protein CaMK4 could enhance blood vessel repair and slow atherosclerosis progression.

Potential therapeutic for Duchenne muscular dystrophy takes step forward

Positive findings from a clinical trial support further study of the investigational drug ifetroban to treat cardiac complications, the leading cause of death in patients with DMD.

Clue to salt-sensitive blood pressure found

Despite the well-established link between high salt intake and cardiovascular disease and stroke, the mechanism of SSBP is poorly understood, and it remains an untreatable cardiovascular risk with no widely available diagnostic tool.

1 2 3 9